# Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

> **NCT04200989** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Scripps Health**

## Conditions studied

- Food Allergy Peanut

## Interventions

- **BIOLOGICAL:** Peanut allergen

## Key facts

- **NCT ID:** NCT04200989
- **Lead sponsor:** Scripps Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2022-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04200989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04200989, "Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04200989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*